Vistin Pharma ASA

OB:VISTN Stock Report

Market Cap: kr1.0b

Vistin Pharma Balance Sheet Health

Financial Health criteria checks 5/6

Vistin Pharma has a total shareholder equity of NOK297.2M and total debt of NOK30.6M, which brings its debt-to-equity ratio to 10.3%. Its total assets and total liabilities are NOK400.4M and NOK103.2M respectively. Vistin Pharma's EBIT is NOK74.4M making its interest coverage ratio 287.3. It has cash and short-term investments of NOK11.4M.

Key information

10.3%

Debt to equity ratio

kr30.61m

Debt

Interest coverage ratio287.3x
Cashkr11.40m
Equitykr297.17m
Total liabilitieskr103.22m
Total assetskr400.38m

Recent financial health updates

Would Vistin Pharma (OB:VISTN) Be Better Off With Less Debt?

Feb 23
Would Vistin Pharma (OB:VISTN) Be Better Off With Less Debt?

We're Keeping An Eye On Vistin Pharma's (OB:VISTN) Cash Burn Rate

Feb 20
We're Keeping An Eye On Vistin Pharma's (OB:VISTN) Cash Burn Rate

Recent updates

Would Vistin Pharma (OB:VISTN) Be Better Off With Less Debt?

Feb 23
Would Vistin Pharma (OB:VISTN) Be Better Off With Less Debt?

A Look At The Fair Value Of Vistin Pharma ASA (OB:VISTN)

Sep 09
A Look At The Fair Value Of Vistin Pharma ASA (OB:VISTN)

Robust Earnings May Not Tell The Whole Story For Vistin Pharma (OB:VISTN)

Aug 25
Robust Earnings May Not Tell The Whole Story For Vistin Pharma (OB:VISTN)

Investors In Vistin Pharma ASA (OB:VISTN) Should Consider This, First

Mar 15
Investors In Vistin Pharma ASA (OB:VISTN) Should Consider This, First

We're Keeping An Eye On Vistin Pharma's (OB:VISTN) Cash Burn Rate

Feb 20
We're Keeping An Eye On Vistin Pharma's (OB:VISTN) Cash Burn Rate

Could The Vistin Pharma ASA (OB:VISTN) Ownership Structure Tell Us Something Useful?

Jan 29
Could The Vistin Pharma ASA (OB:VISTN) Ownership Structure Tell Us Something Useful?

The Vistin Pharma (OB:VISTN) Share Price Is Up 119% And Shareholders Are Boasting About It

Jan 08
The Vistin Pharma (OB:VISTN) Share Price Is Up 119% And Shareholders Are Boasting About It

Have Insiders Been Selling Vistin Pharma ASA (OB:VISTN) Shares?

Dec 16
Have Insiders Been Selling Vistin Pharma ASA (OB:VISTN) Shares?

Is Vistin Pharma ASA (OB:VISTIN) At Risk Of Cutting Its Dividend?

Nov 26
Is Vistin Pharma ASA (OB:VISTIN) At Risk Of Cutting Its Dividend?

Financial Position Analysis

Short Term Liabilities: VISTN's short term assets (NOK149.9M) exceed its short term liabilities (NOK92.7M).

Long Term Liabilities: VISTN's short term assets (NOK149.9M) exceed its long term liabilities (NOK10.5M).

Debt to Equity History and Analysis

Debt Level: VISTN's net debt to equity ratio (6.5%) is considered satisfactory.

Reducing Debt: VISTN's debt to equity ratio has increased from 0% to 10.3% over the past 5 years.

Debt Coverage: VISTN's debt is well covered by operating cash flow (241.6%).

Interest Coverage: VISTN's interest payments on its debt are well covered by EBIT (287.3x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.